POP-1 protein is similar to the Wnt pathway transcription factor TCF-1/LEF-1, which has been shown in other systems to function as either an activator or a repressor. We have previously shown that POP-1 protein is higher in MS than in E in 8-cell embryos and that Wnt signaling regulates a POP-1 dependent switch between MS and E cell fate. In
pop-1 mutant embryos the MS blastomere adopts the fate of its sister, E, and produces endoderm. POP-1 could therefore function as either a repressor of E fate or an activator of MS fate. Complicating the design of a genetic screen for POP-1 targets is the fact that POP-1 may independently regulate multiple genes, mutations in which individually generate phenotypes different from
pop-1 . Therefore, we have undertaken a molecular screen to identify zygotic genes transcribed in the 8-12 cell embryo, on the assumption that POP-1 targets should be amongst these new transcripts. We reasoned that subtraction of cDNA prepared from a 12-cell wild-type embryo against cDNA prepared from a 4-cell embryo would enrich for newly synthesized zygotic transcripts over this 30-minute time period while at the same time removing the highly abundant maternal transcripts shared by both embryos. We have used an extremely sensitive RT-PCR protocol to prepare total 3' EST cDNA from individual staged embryos. The integrity, yield and developmental stage of each single-embryo total cDNA have been confirmed using 3'-end probes from two ubiquitous maternal transcripts (
tba-2 and
ncc-1 ) and two early zygotic transcripts (
end-1 and
pes-10 ) (1,2). A subtraction has been carried out with 12-cell cDNA as tracer and 4-cell cDNA as driver, and efficiency of subtraction measured by the removal of ubiquitous sequences concomitant with the relative elevation of 12-cell specific sequences. We are using 3' cDNAs prepared from individual staged embryos from mutants that either have an MS to E fate transition (
pop-1 ), an E to MS transition (
mom-2 ;
lit-1 ), or that lack MS and E (
skn-1 ) to assign subtraction products to particular blastomeres. In addition, we are sequencing the subtraction clones. Finally, RNAi will be utilized as a final screen to assay the function of selected clones in MS and E blastomeres. 1. Development 120: 2823. 2. G&D 11: 2883.